# Phase 1C — Scientific Hardening Summary

Phase 1C targeted the gap between a strong 9.5+ research build and a more reviewer-resistant 9.7+ build.

## Added
- Pallas local assistant, with no API key or remote inference dependency.
- Personal timed-performance log and personal-history comparisons.
- PMData ATHENA-specific next-day wellness/readiness experiment using all 16 public participant wellness files.
- Leave-one-participant-out wellness transfer test.
- Participant-cluster wellness bootstrap, ablations, robustness, and failure observatory.
- Strong direct nonlinear HGB performance comparator.
- Event-conditional uncertainty diagnostic that was tested and rejected.
- Expanded research UI and automated QA for all of the above.

## Preserved scientific boundaries
- Primary NRCD performance and secondary PMData wellness are not merged.
- PMData is not treated as medical readiness evidence.
- The wellness participant-level confidence interval crosses zero and is disclosed.
- A more complex comparator is retained even though it loses.
- A more complex interval method is retained as rejected rather than silently removed.
- Prospective Validation Mode remains software-complete but empirical-result-empty until real future data exist.

## Release judgment
Phase 1C is judged at approximately **9.72/10 implemented-build quality**. The remaining path toward a near-perfect research package is mostly external evidence: prospective observations, larger independent replication, outside reproduction, usability/comprehension evidence, and a final literature novelty audit.
